Shifting from Reactive to Predictive Care
We face a fascinating but critical challenge in the GCC. The region has one of the youngest populations in the world. In Dubai, residents under 35 make up 60.4% of the total population, and the UAE’s median age sits at around 31 years, younger than the global median. Yet lifestyle-related chronic conditions are showing up far earlier than you’d expect in such a young population.
Diabetes prevalence among UAE adults stands at roughly 20.7%, and Saudi Arabia ranks among the top ten countries globally for diabetes prevalence. Regionally, the Eastern Mediterranean region has the second-highest diabetes prevalence in the world, and the number of people living with diabetes across the MENA region is projected to rise sharply by 2050.
Cardiovascular disease follows the same pattern: Studies from Gulf heart registries, like Gulf RACE, found that people in the region develop heart disease about ten years earlier, on average, than people in Europe. Research from Saudi Arabia backs this up, showing that coronary artery disease also tends to appear about a decade earlier here than the global average. The Gulf region shows a threefold higher prevalence of familial hyperlipidemia compared with Western societies, which causes high cholesterol from birth.
This is what experts call the “GCC health paradox”: a young, dynamic population carrying an old population’s disease burden. It means our industry can no longer afford to wait for a patient to become symptomatic before we intervene.
The future of medicine isn’t just preventive; it is predictive.
This shift is already underway at a policy level, Abu Dhabi’s 2025 Declaration on Longevity and Precision Medicine set out a regional blueprint for integrating AI, genomics, and precision healthcare into mainstream medical practice. Along with national efforts like the Emirati Genome Program are already helping identify hereditary disease risks before symptoms ever appear. The market is following the science: the UAE’s longevity market is forecast to grow from $19 billion in 2020 to $32 billion by 2026.
Sources:
Declaration on longevity and precision medicine launched at Abu Dhabi Global Health Week by Department of Health – Abu Dhabi, April 2025
From healthcare to healthspan: Why predictive, personalised care will define the next era of global health by Gulf News, April 2026
Conclusion
Through Arabian Life, our focus is on bringing together long-term health tracking, advanced testing, and genetic insight to build a clearer picture of each person’s risk. By focusing on health at the cellular level in someone’s 30s and 40s. The exact age when problems in this region tend to start, we’re not just treating disease after it appears. We’re stopping it before it ever takes hold.
Contact us today to learn how predictive, genomics-driven healthcare can help you take control of your health before symptoms ever surface. The best time to act on your health is before you need to.